Target intelligence / Profile preview

Brain mitochondrial carrier protein 1 (SLC25A14)

Target
SLC25A14
Molecular classification
Transporter, Mitochondrial carrier, Mitochondrial uncoupling protein, Solute carrier (SLC) family
01

Overview

Brain mitochondrial carrier protein 1 (SLC25A14, also known as UCP5 or BMCP1) is a mitochondrial inner membrane transporter belonging to the solute carrier 25 (SLC25) family, specifically the mitochondrial uncoupling protein (UCP) group. SLC25A14 is primarily expressed in the brain but also present in testis and pituitary. Its main functions include mediating the mitochondrial proton leak (uncoupling oxidative phosphorylation from ATP synthesis) and facilitating the transport of various inorganic anions (such as sulfate, sulfite, thiosulfate, and phosphate) and amino acids (notably aspartate and glutamate) across the inner mitochondrial membrane. Through these activities, SLC25A14 modulates mitochondrial membrane potential, mitigates oxidative stress, regulates mitochondrial efficiency and apoptosis, and provides neuroprotection under oxidative or metabolic stress conditions. SLC25A14 has been implicated in neurodegenerative diseases and aging, as well as broader metabolic and mitochondrial disorders. There are currently no clinically approved drugs known to directly target SLC25A14.

Other names
Brain mitochondrial carrier protein 1SLC25A14BMCP1UCP5UNQ791/PRO1682BMCP-1mitochondrial uncoupling protein 5brain mitochondrial carrier protein 1solute carrier family 25 member 14
02

Mechanism of action

Uncoupling of oxidative phosphorylation from ATP synthesis by facilitating proton and anion transport across the mitochondrial inner membrane, reduction of mitochondrial membrane potential, modulation of oxidative and metabolic stress responses

03

Biological functions

Mitochondrial proton leakRegulation of mitochondrial membrane potentialModulation of oxidative phosphorylationTransport of inorganic anions (sulfate, sulfite, thiosulfate, phosphate)NeuroprotectionRegulation of apoptosisRegulation of oxidative stressEnergy metabolism
04

Disease associations

Neurodegenerative diseaseAgingIschemiaMetabolic disordersPotential cardiovascular and metabolic disease association
05

Safety considerations

Potential mitochondrial dysfunctionrisks related to altered ATP productionand perturbation of neuronal oxidative balance

Beyond the preview

Go deeper on Brain mitochondrial carrier protein 1 (SLC25A14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain mitochondrial carrier protein 1 (SLC25A14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call